Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomePreferred Dividend PaymentsProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

TriSalus Life Sciences (TLSI) Tax Provisions (2022 - 2025)

Historic Tax Provisions for TriSalus Life Sciences (TLSI) over the last 4 years, with Q3 2025 value amounting to $5000.0.

  • TriSalus Life Sciences' Tax Provisions rose 26666.67% to $5000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $6000.0, marking a year-over-year decrease of 2500.0%. This contributed to the annual value of $6000.0 for FY2024, which is 3333.33% down from last year.
  • TriSalus Life Sciences' Tax Provisions amounted to $5000.0 in Q3 2025, which was up 26666.67% from -$3000.0 recorded in Q2 2025.
  • Over the past 5 years, TriSalus Life Sciences' Tax Provisions peaked at $28202.0 during Q2 2022, and registered a low of -$5000.0 during Q1 2023.
  • Over the past 4 years, TriSalus Life Sciences' median Tax Provisions value was $4000.0 (recorded in 2024), while the average stood at $4683.5.
  • In the last 5 years, TriSalus Life Sciences' Tax Provisions crashed by 20000.0% in 2024 and then surged by 26666.67% in 2025.
  • TriSalus Life Sciences' Tax Provisions (Quarter) stood at $6000.0 in 2022, then plummeted by 83.33% to $1000.0 in 2023, then tumbled by 200.0% to -$1000.0 in 2024, then skyrocketed by 600.0% to $5000.0 in 2025.
  • Its Tax Provisions stands at $5000.0 for Q3 2025, versus -$3000.0 for Q2 2025 and $5000.0 for Q1 2025.